Cyclosporine is an effective drug in the treatment of severe remittent anemia. Reasonable application of cyclosporine can alleviate the condition and improve the prognosis, but there is no guarantee that it can be absolutely cured.
The full name of remyelination is aplastic anemia, which is a kind of bone marrow hematopoietic failure caused by multiple etiologies and pathogenesis, mainly manifested as low proliferation of bone marrow nucleated cells, reduction of whole blood cells, and prone to anemia, hemorrhage and infection. Retrovascularization can be classified as non-severe, severe and very severe.
The treatment of remyelination should be based on the patient’s condition to take comprehensive measures, such as anemia, bleeding, infection, should be targeted treatment to correct anemia, hemostasis, prevention of bleeding, control of infection, the drugs include aminomethylenic acid, levofloxacin and so on.
For non-severe retroviruses, cyclosporine is usually preferred, supplemented by androgenic drugs such as testosterone undecanoate, etc., and severe retroviruses such as no contraindications.
After cyclosporine and other drugs standardized treatment, non-severe cataract patients are expected to get effective relief. In contrast, severe reocclusion is more serious and has a poor prognosis; the use of cyclosporine can alleviate the condition but does not guarantee a cure for the disease.
Adverse reactions include infection, skin rash, immune dysfunction, etc. Cyclosporine should be used with caution in patients with immunodeficiency, severe liver and kidney impairment.
If the diagnosis of aplastic anemia is confirmed, it is necessary to go to a regular medical institution to follow the doctor’s instructions to standardize the treatment.